VNA
INO icon

Valley National Advisers’s Inovio Pharmaceuticals INO Stock Holding History

Valley National Advisers’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27 Buy
+24
New +$28 ﹤0.01% 1043
2024
Q4 		– Sell
-636
Closed -$3K – 782
2024
Q3 		$3K Hold
636
– – ﹤0.01% 628
2024
Q2 		$5K Hold
636
– – ﹤0.01% 756
2024
Q1 		$8K Sell
636
-2
-0.3% -$17 ﹤0.01% 695
2023
Q4 		$3K Hold
638
– – ﹤0.01% 880
2023
Q3 		$3K Sell
638
-694
-52% -$3.83K ﹤0.01% 767
2023
Q2 		$8K Hold
1,332
– – ﹤0.01% 639
2023
Q1 		$14K Buy
1,332
+629
+89% +$10.7K ﹤0.01% 551
2022
Q4 		$14K Sell
703
-350
-33% -$7.93K ﹤0.01% 536
2022
Q3 		$23K Hold
1,053
– – ﹤0.01% 478
2022
Q2 		$27K Buy
1,053
+28
+3% +$789 0.01% 431
2022
Q1 		$44K Buy
1,025
+283
+38% +$12.7K 0.01% 390
2021
Q4 		$44K Sell
742
-250
-25% -$20K 0.01% 380
2021
Q3 		$85K Sell
992
-166
-14% -$16.7K 0.02% 298
2021
Q2 		$129K Buy
1,158
+183
+19% +$17.6K 0.02% 255
2021
Q1 		$109K Sell
975
-333
-25% -$43.8K 0.02% 267
2020
Q4 		$139K Hold
1,308
– – 0.03% 227
2020
Q3 		$182K Buy
1,308
+200
+18% +$41.7K 0.04% 180
2020
Q2 		$358K Buy
1,108
+125
+13% +$20.1K 0.08% 144
2020
Q1 		$88K Buy
983
+145
+17% +$8.94K 0.02% 218
2019
Q4 		$33K Hold
838
– – 0.01% 356
2019
Q3 		$21K Buy
+838
New +$25.5K 0.01% 412

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Valley National Advisers's INO Position: Q2 2026 in Review

Valley National Advisers opened a new position in Inovio Pharmaceuticals (INO) in Q2 2026: 24 shares worth $27. The stake represents ﹤0.01% of the portfolio and ranks #1043 among its holdings. This is a return to the name: Valley National Advisers previously reported a position in INO as recently as Q3 2024.

Valley National Advisers first reported a position in INO in Q3 2019 and has held it in 22 quarters since. The position peaked at $358K in Q2 2020. 102 funds tracked by Wall St. Rank hold INO as of Q2 2026.

  • Valley National Advisers held 24 shares of Inovio Pharmaceuticals worth $27 as of Q2 2026.
  • Inovio Pharmaceuticals was a new Valley National Advisers position in Q2 2026.
  • Inovio Pharmaceuticals made up ﹤0.01% of Valley National Advisers's portfolio in Q2 2026, its #1043 holding.
  • Valley National Advisers first reported a position in Inovio Pharmaceuticals in Q3 2019 and has held it in 22 quarters since.
  • Valley National Advisers's Inovio Pharmaceuticals position peaked at $358K in Q2 2020.
  • 102 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on Valley National Advisers's 13F filing for Q2 2026, filed 29 Jul 2026.